Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
IBB vs FBT
Shared holdings
28
IBB covered by FBT
42.48%
FBT covered by IBB
42.48%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
IBB (March 31, 2026)
| Security | Weight | |
|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 8.81% | |
| GILEAD SCIENCES INC | 7.06% | |
| AMGEN INC | 6.84% | |
| VERTEX PHARMACEUTICALS INC | 6.79% | |
| REGENERON PHARMACEUTICALS INC | 6.58% | |
| ALNYLAM PHARMACEUTICALS INC | 3.64% | |
| INSMED INC | 2.91% | |
| ARGENX SE SPONSORED ADR | 2.80% | |
| BIOGEN INC | 2.25% | |
| NATERA INC | 2.20% | |
| UNITED THERAPEUTICS CORP DEL | 2.10% | |
| BEONE MEDICINES LTD ADR | 1.76% | |
| INCYTE CORP | 1.55% | |
| MODERNA INC | 1.54% | |
| ILLUMINA INC | 1.53% | |
| REVOLUTION MEDICINES INC | 1.40% | |
| ROIVANT SCIENCES LTD | 1.13% | |
| NEUROCRINE BIOSCIENCES INC | 1.08% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 1.07% | |
| BRIDGEBIO PHARMA INC | 1.03% | |
| IONIS PHARMACEUTICALS INC | 1.02% | |
| MEDPACE HOLDINGS INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.91% | |
| EXELIXIS INC | 0.90% | |
| BIOMARIN PHARMACEUTICAL INC | 0.90% | |
| Ascendis Pharma A/S | 0.87% | |
| PRAXIS PRECISION MEDICINES INC | 0.71% | |
| CHARLES RIVER LABS INTL INC | 0.70% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.69% | |
| VAXCYTE INC | 0.68% | |
| BIO-TECHNE CORP | 0.68% | |
| CYTOKINETICS INC | 0.66% | |
| HALOZYME THERAPEUTICS INC | 0.63% | |
| AXSOME THERAPEUTICS INC | 0.61% | |
| BIONTECH SE ADR | 0.60% | |
| KRYSTAL BIOTECH INC | 0.55% | |
| PROTAGONIST THERAPEUTICS INC | 0.53% | |
| REPLIGEN CORP | 0.52% | |
| KYMERA THERAPEUTICS INC | 0.49% | |
| ALKERMES PLC | 0.48% | |
| RHYTHM PHARMACEUTICALS INC | 0.46% | |
| Abivax SA SPONSORED ADS | 0.46% | |
| PTC THERAPEUTICS INC | 0.45% | |
| COGENT BIOSCIENCES INC | 0.44% | |
| ARCELLX INC | 0.43% | |
| TERNS PHARMACEUTICALS INC | 0.42% | |
| NUVALENT INC-A | 0.41% | |
| MIRUM PHARMACEUTICALS INC | 0.41% | |
| TEMPUS AI INC-A | 0.39% | |
| XENON PHARMACEUTICALS INC | 0.39% |
FBT (March 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 5.26% | |
| UNITED THERAPEUTICS CORP DEL | 4.36% | |
| ALKERMES PLC | 4.23% | |
| GILEAD SCIENCES INC | 4.09% | |
| AXSOME THERAPEUTICS INC | 3.88% | |
| AMGEN INC | 3.83% | |
| CORCEPT THERAPEUTICS INC | 3.82% | |
| KRYSTAL BIOTECH INC | 3.51% | |
| BIOGEN INC | 3.47% | |
| EXELIXIS INC | 3.46% | |
| NEUROCRINE BIOSCIENCES INC | 3.44% | |
| REGENERON PHARMACEUTICALS INC | 3.44% | |
| VERTEX PHARMACEUTICALS INC | 3.42% | |
| BIOMARIN PHARMACEUTICAL INC | 3.40% | |
| ARGENX SE SPONSORED ADR | 3.29% | |
| SAREPTA THERAPEUTICS INC | 3.24% | |
| HALOZYME THERAPEUTICS INC | 3.17% | |
| BIONTECH SE ADR | 3.16% | |
| INCYTE CORP | 3.13% | |
| BEONE MEDICINES LTD ADR | 3.12% | |
| ILLUMINA INC | 3.10% | |
| NATERA INC | 3.03% | |
| ACADIA PHARMACEUTICALS INC | 2.95% | |
| ALNYLAM PHARMACEUTICALS INC | 2.95% | |
| BIO-TECHNE CORP | 2.82% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 2.78% | |
| VERACYTE INC | 2.72% | |
| REPLIGEN CORP | 2.51% | |
| BRUKER CORP | 2.35% | |
| NEOGENOMICS INC | 2.00% | |
| DREY-GVT CSH-I | 0.06% | |
| DAIWA CAPITAL MARKETS AMERICA INC | 0.01% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.